Camide

Quick links to important sections

Camide

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Camide

What is Camide?

Property Description
Active ingredient Tropicamide
Form Ophthalmic solution (Eye drops)
Pharmacological class Anticholinergic (Antimuscarinic) Agent
Common use Diagnostic aid in eye examinations
Origin Synthetic

Camide is a recognized trade name for a prescription-only medicine used to temporarily alter the function of the eye for diagnostic purposes. Its composition is the single active ingredient known generically as Tropicamide. It is available as a sterile, water-based solution, designed for ophthalmic (topical eye) administration.

Camide: A Diagnostic Ophthalmic Agent

Camide is a solution whose singular purpose is to serve as a diagnostic aid during comprehensive eye examinations, distinguishing it from agents intended for long-term treatment. The primary utility of Tropicamide is its quick-acting ability to produce mydriasis (pupil dilation) for fundus examinations and refractive testing. The medicine is clinically recognized for its reliable performance in procedures requiring a stable, dilated pupil, ensuring that practitioners can conduct a thorough assessment of the eye's internal structures.

Tropicamide: Composition and Pharmacological Class

The active chemical compound in the solution is Tropicamide, a substance classified as a synthetic compound derived from tropic acid. Its precise pharmacological action places it within the anticholinergic agent class, operating as a muscarinic antagonist. It serves as a mydriatic agent for diagnostic procedures and is manufactured as a single-ingredient product, typically available as an aqueous vehicle solution in concentrations of either 0.5% or 1.0%.

The Functional Effects: Mydriasis and Cycloplegia

The medicine is used to produce two primary physiological effects essential for eye assessment: Mydriasis (the dilation, or widening, of the pupil) and Cycloplegia (the temporary paralysis of the eye's focusing mechanism). The dilation of the pupil provides the practitioner with an unobstructed view of the retina and the interior of the eye. Concurrently, the effect of cycloplegia relaxes the focusing muscles, which is essential for obtaining a stable and reliable measurement of the eye’s refractive error during the examination.

What side effects are possible with Camide?

Possible Side Effects and Safety Information

The officially documented safety profile of Camide (Tropicamide) covers a range of reactions classified primarily by their effect on the eye or as systemic anticholinergic responses.

Adverse reactions are grouped by their effect on specific organ systems, as classified in regulatory summaries. Common and functional effects include transient stinging or burning immediately after application, blurred vision, and photophobia (increased sensitivity to light), which are expected functional consequences of the medicine's action. Systemic anticholinergic effects that may be reported include dry mouth, headache, and flushing.

System-Organ Class (SOC) Examples of Officially Listed Reactions
Eye Disorders Increased intraocular pressure, ocular hyperaemia
Nervous System Dizziness, headache
Psychiatric Disorders Psychotic reactions, confusion, hallucinations
Cardiac Disorders Tachycardia, palpitations

Serious adverse reactions documented in regulatory sources include the precipitation of acute angle-closure glaucoma in individuals with a narrow filtration angle, which is a key contraindication for use. The risk profile is also conditional regarding specific populations. Pediatric patients, especially infants and small children, have an increased susceptibility to systemic toxicity and CNS disturbances, including serious behavioral changes or, rarely, cardiorespiratory collapse. Special caution is necessary for older adults due to the risk of undiagnosed glaucoma. The effects on the pupil (mydriasis) may be prolonged, with full recovery potentially taking up to 24 hours.

Overdose and Emergency Response

Overdosage of Camide (Tropicamide ophthalmic solution), particularly from accidental ingestion or significant systemic exposure, is defined by signs of acute anticholinergic toxicity. Documented manifestations include flushing and dryness of the skin, blurred vision, fever, headache, vomiting, agitation, and a rapid, irregular pulse. Serious consequences involve the Central Nervous System and the cardiovascular system, with potential risks such as hypertension, cardiac arrhythmias, hallucinations, convulsions, and a loss of neuromuscular coordination.

Systemic toxicity is a documented concern particularly in children and infants, where specific signs like abdominal distension may occur, and there is a greater vulnerability to severe outcomes. Official regulatory guidance requires seeking immediate medical attention or contacting a regional Poison Control Centre for any suspected systemic overdosage.

Management is documented as symptomatic and supportive treatment, given that no specific antidote is known to be superior to supportive measures. For ocular overdosage, flushing the eye with lukewarm water is an officially recommended measure, and procedures like inducing emesis or performing gastric lavage may be considered for accidental ingestion of large doses. Careful monitoring is required for all patients with systemic overdosage.

Therapeutic Uses of Camide

What Camide Treats: Main Uses and Benefits

Camide is generally considered relevant across therapeutic contexts involving temporary physiological alteration of the eye for diagnosis and supportive relief during acute inflammation. The core utility is supporting ophthalmic diagnosis and the easing of discomfort in specific inflammatory states. The medication is primarily applied for diagnostic procedures addressing symptoms linked to organ-specific functional stress.

The primary indications where this medicine is commonly used include: comprehensive eye examinations, testing related to visual focus, pre-operative surgical assessment, and the management of acute anterior uveitis or iritis. The application supports practitioners in conducting a thorough examination and assists with maintaining functional stability in inflammatory conditions.

Supporting Ophthalmic Diagnosis and Assessment

Camide is used in clinical settings where a detailed view of the inner structures of the eye is considered relevant for diagnosis. It is applied to address the symptoms related to organ-specific functional stress from the eye's focusing efforts. This action supports practitioners in conducting a thorough examination of the retina and optic nerve, which is generally relevant for screening conditions like diabetic retinopathy or before procedures such as cataract surgery.

Quick Fact: Addressing Symptoms of Muscular Tension This medication is generally used to address symptoms of increased neurological or muscular activity, specifically relaxing the eye’s internal focusing mechanism to support obtaining stable measurements.

Regulatory References

  1. FDA-approved label via NIH DailyMed

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Camide — Official Regulatory Information

The eligibility for Camide (Tropicamide ophthalmic solution) is strictly defined by national regulatory documents, excluding certain populations due to specific health risks and lack of data.

Eligibility Category Status Official Restriction
Absolute Contraindication Must NOT use Known or suspected narrow angle glaucoma and hypersensitivity to any component [Source 1.2, 1.4].
Age-Related Restriction Use is Not Recommended Small infants (e.g., under 3 months) due to high risk of systemic toxicity and Central Nervous System (CNS) disturbances [Source 1.2].
Pregnancy Status Use Only if Clearly Needed Classified as FDA Category C; use during pregnancy is not recommended unless essential for the diagnostic procedure [Source 1.4, 3.2].
Comorbidity Caution Use with Caution Patients with pre-existing hypertension, hyperthyroidism, specific cardiac disorders, or diabetes mellitus [Source 1.6].
Insufficient Data Groups Safety Not Established Patients with hepatic impairment (liver) or renal impairment (kidney) [Source 2.4, 3.7].

The regulatory profile consistently establishes absolute exclusions based on ocular risk, while defining conditional eligibility for age groups and those with chronic systemic diseases. This structure mandates specific precautions or outright prohibition, reserving the medicine for the labeled population under appropriate circumstances.

What should I know about interactions with other medicines?

The official interaction profile for Camide (Tropicamide) is defined by its potential for pharmacodynamic interactions, which do not involve metabolic enzyme pathways like CYP or drug transporters. These documented interactions fall into two primary categories based on official regulatory labeling.

Additive Anticholinergic Effects

Co-administration with other medicinal products that possess antimuscarinic properties may result in the enhancement of systemic effects. This includes drug classes such as certain tricyclic antidepressants, antihistamines, and phenothiazine antipsychotics. The specific medicine Amantadine is also listed in this category.

Pharmacodynamic Antagonism

Camide may interfere with the intended action of certain other ophthalmic solutions. This antagonism is specifically documented to diminish the antihypertensive action of cholinergic agents like carbachol, pilocarpine, and ophthalmic cholinesterase inhibitors.

Interaction-Related Restrictions Status in Regulatory Documents
Contraindicated Combinations No specific drug-drug combinations are formally listed as contraindicated.
Food or Drinks No known interactions are documented.
Non-Drug Product Timing Soft contact lenses must be removed prior to application.

Official warnings highlight a population-specific risk, noting the increased susceptibility of pediatric patients to central nervous system disturbances resulting from the anticholinergic class effect. This information establishes the documented restrictions and regulatory context for use.

Mechanism of Action

Modulation of Receptor-Mediated Signaling

Camide operates primarily by engaging mechanisms that regulate overactive or dysregulated processes within the nervous system. The drug initiates or suppresses signaling sequences that lead to downstream effects by affecting systems where specific transmitters or mediators dominate. This results in the contributing to regulating overactive physiological responses.


Regulation of Key Pathway Activation

The drug's action extends to modulating key pathways associated with heightened physiological responses. It achieves this by modifying early molecular steps that shape systemic physiological outcomes, particularly in cascades where multiple layers of pathway activation occur. This mechanistic focus leads to resulting physiological adjustments that modulates pathway activity toward a regulated state.


Influence on Feedback Regulation

Camide is also relevant in systems where targeted pathway adjustment is required, as it engages mechanisms that influence feedback regulation within pathways. This action decreases excessive mediator activity, thereby modulates the regulation of processes driven by distinct signaling patterns.

Dosage and Administration Information

Administration Overview

Camide is an oral medication that should be taken exactly as recommended by a healthcare provider. Consistency in how the medication is taken is important for maintaining stable levels in the body.

General Guidelines

  • Method: The tablets should be swallowed whole with a glass of water. They should not be crushed, chewed, or broken unless specifically advised otherwise.
  • Timing: It is generally recommended to take the medication at the same time each day to help maintain a routine and ensure consistent absorption.
  • Food Interaction: Camide can be taken either with or without food. However, if stomach upset occurs, taking it alongside a meal may help improve tolerance.

Missing a Dose

If a scheduled dose is missed, it should be taken as soon as it is remembered. If it is nearly time for the next scheduled dose, the missed dose should be bypassed to resume the regular schedule. Do not take multiple doses at once to make up for a missed one.

Considerations for Use

Patients should continue taking the medication for the full duration of the period recommended by their healthcare professional, even if symptoms appear to improve early. Sudden discontinuation should be avoided unless discussed with a medical professional. Monitoring by a healthcare provider may be necessary during the course of use to evaluate how the body is responding to the medication.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Camide (Tropicamide)

The clinical research for Camide is primarily focused on its short-term use as a diagnostic tool. Evidence is largely drawn from Randomized Controlled Trials (RCTs) and systematic reviews that monitor immediate, measurable changes in eye function.

Research Evidence for Pupil Dilation (Mydriasis)

This section will summarize the structure of clinical research, primarily focusing on Randomized Controlled Trials (RCTs), that examined the functional measurement of pupil size change and the time-dependent effects of the medicine for diagnostic purposes.

Research explored the use of Camide in contexts relevant in trials assessing short-term diagnostic patterns. The most common studies have been comparative RCTs where researchers examined two main outcomes: the degree of pupil widening achieved and the total duration of the measured change. Studies report measurements showing that the largest change in pupil size generally occurred within 20 to 30 minutes after instillation. Pupil measurements often returned to pre-application values within 4 to 8 hours.

Clinical Evaluation for Refractive Testing (Cycloplegia)

This section will outline the research base, including meta-analyses and comparative studies, that evaluated the functional measurements of the eye's focusing mechanism (accommodation) and its temporary relaxation for accurate refractive error determination.

Studies examined outcomes related to systemic or functional imbalance by measuring the amount of residual focusing power and the final measurement of the spherical equivalent refractive error. Some meta-analyses reported that no statistically significant differences in the final refractive error measurements were observed when compared with other agents in specific groups, such as non-strabismic adults. Research highlights measurements related to the time until recovery of focusing ability, which was often reported as being within 6 to 10 hours.

Research Gaps and Areas of Uncertainty

The overall evidence quality varies across studies, particularly between the high-level RCTs for diagnostic use and the observational data for the supportive role in inflammation. Subgroup findings are uncertain for very young children and individuals with certain eye conditions where a complete elimination of focusing power is paramount. Additionally, comparative evidence is lacking in some areas, as some studies examine the medicine alongside other agents, making its isolated contribution less clear. Research provides context but not individual predictions, and findings describe group patterns, not personal outcomes.

Key Studies & References

  1. Tropicamide Ophthalmic Solution, USP 1% (FDA/DailyMed Label)
  2. Comparison of cycloplegic effects of atropine and tropicamide in children with refractive error

Frequently Asked Questions (FAQ)

Common questions about Camide (FAQ)

Q: Can Camide affect my ability to drive or operate machinery?

Since Camide causes the pupil to widen and can result in blurred vision, official regulatory information advises caution. Patients who experience dilated pupils or blurred vision should avoid driving or operating hazardous machinery until their vision has completely normalized.


Q: How does Camide interact with common over-the-counter pain relievers?

The official interaction profile does not specifically list common over-the-counter (OTC) pain relievers. Official guidance indicates the importance of discussing all non-prescription products, including common OTC medicines, with a healthcare professional before use.


Q: Is Camide safe for people over the age of 65?

Regulatory data indicates that no overall differences in the effectiveness or general safety profile have been observed between elderly and younger adult patients. However, official guidance indicates specific precautions for older adults due to the potential risk of undiagnosed narrow-angle glaucoma.


Q: Can children or adolescents use Camide?

Regulatory documents state that the 1% strength solution is generally not intended for use in small infants (e.g., under three months of age). Official information cautions that the drug class may rarely cause temporary central nervous system (CNS) disturbances in pediatric patients.


Q: Why do some people experience mild headaches when they first take Camide?

Headache is listed in official safety documents as a potential side effect of Camide. This reaction may be related to the drug's anticholinergic effects on the nervous system or vascular system.


Q: Why is Camide not suitable for people with certain heart conditions?

Official safety information notes that reported side effects can include tachycardia (a fast heart rate) or palpitations. For this reason, caution may be warranted for individuals with pre-existing cardiac disorders.


Q: Are there any long-term health concerns associated with taking Camide?

As Camide is intended for short-term, diagnostic use, official regulatory documents indicate that long-term studies to evaluate potential effects, such as carcinogenic risk in animals, have not been performed.


Q: Is there a generic version of Camide available?

Yes, the active ingredient in Camide is generically known as Tropicamide. This active ingredient is available from various manufacturers both under the brand name and as a generic ophthalmic solution.


Q: Is it common to feel tired after starting Camide?

Official safety documentation includes reported side effects such as drowsiness, somnolence (sleepiness), tiredness, or weakness. These effects are reported in official safety documentation and may be related to the minimal systemic absorption of the drug.


Q: Does taking Camide affect fertility in men or women?

Official product labeling includes a statement regarding the potential for impairment of fertility. However, regulatory documents also state that no long-term studies have been conducted in animals to fully evaluate fertility potential.


Q: What is the expiration time frame for Camide tablets?

Camide is an ophthalmic solution (eye drops), not a tablet. The specific expiration date is provided on the product packaging by the manufacturer. Additionally, if the product is a single-dose unit, official guidance is to discard any remaining solution immediately after use.


Q: What are the signs of a serious allergic reaction to Camide?

Regulatory safety materials caution against use in cases of known hypersensitivity to any component of the solution. Signs of a serious allergic reaction may include skin rash, itching, hives, or swelling of the face, lips, tongue, or throat.


Q: If I am taking vitamins, is it okay to take Camide?

Official guidance indicates the importance of discussing the use of all products you are taking, including vitamin supplements, with a healthcare professional. This helps ensure that the diagnostic procedure and the medication's effects are not unexpectedly altered.


Q: What happens if I accidentally take two doses of Camide close together?

Since Camide is an eye solution with a very low concentration of the active ingredient, accidental swallowing is considered unlikely to cause severe side effects. Official patient information indicates that in the event of accidental ingestion, a poisons information center or a doctor should be contacted immediately.


Q: Does Camide interact with herbal supplements like St. John's Wort?

No specific interaction is documented for herbal supplements like St. John's Wort in the drug's official interaction profile. General regulatory guidance indicates the importance of discussing the use of all supplements, including herbal products, with a healthcare professional.


Q: What is the molecular structure or formula of Camide?

The active ingredient in Camide is the synthetic compound known as Tropicamide. Its chemical properties are described by the molecular formula C17H20N2O2.


Q: Does Camide interact with alcohol?

The regulatory labeling for Camide does not list a specific interaction with alcohol. However, official guidance indicates the importance of discussing the use of alcohol with a healthcare professional.


Q: Is it true that Camide can affect sleep patterns?

Official safety data has associated the drug with systemic side effects such as drowsiness, somnolence, and other central nervous system disturbances. These types of reported effects may potentially impact sleep patterns.


Q: How quickly is Camide eliminated from the body?

The drug's primary functional effects (pupil widening) are short-lived, with the duration of activity being approximately three to eight hours. Official data notes that while the duration of activity is typically three to eight hours, complete recovery from pupil dilation may require up to 24 hours in some individuals.


Q: Does Camide require any special monitoring or lab tests?

According to official regulatory information, no specific diagnostic exams or specialized lab tests are generally required for monitoring the use of Camide.


Q: What is the purpose of the 'inactive ingredients' in Camide tablets?

Camide is an ophthalmic solution (eye drops), not a tablet. The inactive ingredients, which may include substances like a preservative or sodium chloride, serve important functions. These ingredients ensure the solution is sterile, stable, and has the correct pH level for safe use in the eye.


Q: Have there been any major studies comparing Camide to placebo?

Yes, the clinical research used to establish the drug's efficacy often includes randomized, controlled studies. Official evidence summaries confirm that clinical research for mydriasis has included double-masked, placebo-controlled studies.

How should Camide be stored and disposed of?

Storage Conditions

Camide (Tropicamide Ophthalmic Solution) must be stored strictly according to the official regulatory guidelines to maintain its stability and effectiveness.

Storage Requirement Official Condition (FDA/NIH)
Temperature Store at controlled room temperature (20 C to 25 C / 68 F to 77 F), protected from temperature excursions.
Handling & Container Protect from freezing. Keep the solution in its original container and ensure the container is tightly closed when not in use.
Child Safety Keep out of the reach of children.

Disposal Instructions

Unused or expired Camide must be disposed of in accordance with local requirements. Official regulatory guidance advises against flushing the solution down a sink or toilet. Instead, if a local drug take-back program is unavailable, follow the general procedure of mixing the product with an undesirable substance before discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Camide found in:

A-Z Index: